Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 4091 | 15.14 |
09:34 ET | 200 | 15.13 |
09:36 ET | 400 | 15.1517 |
09:38 ET | 3436 | 15.25 |
09:39 ET | 400 | 15.3 |
09:41 ET | 400 | 15.3 |
09:45 ET | 614 | 15.23 |
09:48 ET | 200 | 15.215 |
09:54 ET | 200 | 15.115 |
09:56 ET | 3284 | 15.1 |
09:57 ET | 3480 | 15.1492 |
09:59 ET | 100 | 15.11 |
10:01 ET | 206 | 15.13 |
10:08 ET | 1218 | 15.14 |
10:10 ET | 226 | 15.1 |
10:12 ET | 100 | 15.16 |
10:14 ET | 300 | 15.13 |
10:17 ET | 100 | 15.19 |
10:19 ET | 1110 | 15.23 |
10:21 ET | 1616 | 15.21 |
10:24 ET | 1501 | 15.15 |
10:26 ET | 200 | 15.13 |
10:28 ET | 900 | 15.1 |
10:30 ET | 500 | 15.06 |
10:32 ET | 989 | 15.06 |
10:33 ET | 601 | 15.03 |
10:35 ET | 900 | 15.03 |
10:37 ET | 1261 | 15.07 |
10:39 ET | 1153 | 15.09 |
10:42 ET | 100 | 15.09 |
10:44 ET | 101 | 15.09 |
10:46 ET | 402 | 15.12 |
10:48 ET | 345 | 15.15 |
10:50 ET | 100 | 15.155 |
10:51 ET | 1442 | 15.175 |
10:55 ET | 301 | 15.16 |
10:57 ET | 19350 | 15.11 |
11:04 ET | 627 | 15.11 |
11:06 ET | 100 | 15.14 |
11:08 ET | 2180 | 15.125 |
11:09 ET | 300 | 15.1 |
11:11 ET | 821 | 15.04 |
11:13 ET | 606 | 15 |
11:15 ET | 500 | 15.02 |
11:18 ET | 714 | 15 |
11:20 ET | 1345 | 15.02 |
11:22 ET | 578 | 15.02 |
11:24 ET | 914 | 15.03 |
11:26 ET | 1062 | 15.02 |
11:29 ET | 515 | 15.035 |
11:31 ET | 738 | 15.015 |
11:33 ET | 505 | 15.01 |
11:36 ET | 599 | 14.98 |
11:38 ET | 100 | 15.04 |
11:40 ET | 2249 | 15.07 |
11:42 ET | 577 | 15.1 |
11:44 ET | 1131 | 15.01 |
11:45 ET | 900 | 15.01 |
11:47 ET | 160 | 15.03 |
11:49 ET | 1004 | 14.99 |
11:51 ET | 300 | 14.99 |
11:54 ET | 264 | 15.07 |
11:58 ET | 781 | 15.095 |
12:00 ET | 150 | 15.105 |
12:02 ET | 2009 | 15.12 |
12:03 ET | 200 | 15.13 |
12:05 ET | 400 | 15.125 |
12:07 ET | 1629 | 15.11 |
12:09 ET | 300 | 15.09 |
12:12 ET | 608 | 15.08 |
12:16 ET | 1023 | 15.08 |
12:18 ET | 100 | 15.055 |
12:20 ET | 1000 | 15.09 |
12:21 ET | 100 | 15.085 |
12:23 ET | 5241 | 15.13 |
12:25 ET | 611 | 15.16 |
12:32 ET | 200 | 15.17 |
12:34 ET | 100 | 15.155 |
12:36 ET | 200 | 15.155 |
12:38 ET | 100 | 15.155 |
12:39 ET | 6488 | 15.12 |
12:41 ET | 400 | 15.12 |
12:43 ET | 8831 | 15.05 |
12:48 ET | 100 | 15.06 |
12:50 ET | 308 | 15.07 |
12:52 ET | 6159 | 15.065 |
12:54 ET | 200 | 15.055 |
12:56 ET | 300 | 15.04 |
12:57 ET | 100 | 15.04 |
12:59 ET | 408 | 15.07 |
01:01 ET | 300 | 15.04 |
01:03 ET | 405 | 15.06 |
01:08 ET | 100 | 15.065 |
01:10 ET | 1152 | 15.09 |
01:12 ET | 5570 | 15.105 |
01:14 ET | 450 | 15.11 |
01:15 ET | 6105 | 15.12 |
01:17 ET | 321 | 15.09 |
01:19 ET | 5600 | 15.05 |
01:21 ET | 1000 | 15 |
01:24 ET | 400 | 14.96 |
01:26 ET | 1000 | 14.94 |
01:28 ET | 5086 | 14.96 |
01:30 ET | 9309 | 14.89 |
01:32 ET | 400 | 14.88 |
01:33 ET | 6528 | 14.82 |
01:35 ET | 590 | 14.77 |
01:37 ET | 7235 | 14.8 |
01:39 ET | 1784 | 14.79 |
01:42 ET | 100 | 14.81 |
01:44 ET | 300 | 14.84 |
01:46 ET | 542 | 14.9 |
01:48 ET | 835 | 14.8984 |
01:50 ET | 250 | 14.885 |
01:51 ET | 2775 | 14.84 |
01:53 ET | 200 | 14.82 |
01:55 ET | 1850 | 14.82 |
01:57 ET | 704 | 14.875 |
02:00 ET | 300 | 14.85 |
02:02 ET | 651 | 14.89 |
02:04 ET | 836 | 14.85 |
02:06 ET | 509 | 14.89 |
02:08 ET | 200 | 14.87 |
02:09 ET | 1244 | 14.89 |
02:11 ET | 113 | 14.89 |
02:13 ET | 624 | 14.93 |
02:15 ET | 500 | 14.92 |
02:18 ET | 300 | 14.95 |
02:20 ET | 785 | 14.97 |
02:24 ET | 1181 | 15 |
02:26 ET | 200 | 15 |
02:27 ET | 3731 | 15.06 |
02:29 ET | 1465 | 15.0325 |
02:31 ET | 801 | 15.03 |
02:38 ET | 1232 | 15.03 |
02:42 ET | 400 | 15.04 |
02:44 ET | 266 | 15.05 |
02:45 ET | 2675 | 15.04 |
02:47 ET | 400 | 15.03 |
02:49 ET | 644 | 15.015 |
02:51 ET | 2569 | 14.98 |
02:54 ET | 211 | 15 |
02:56 ET | 300 | 15 |
02:58 ET | 225 | 15 |
03:00 ET | 1396 | 15.01 |
03:02 ET | 915 | 15.03 |
03:03 ET | 1325 | 15.03 |
03:05 ET | 2564 | 15.08 |
03:07 ET | 2867 | 15.12 |
03:09 ET | 3442 | 15.11 |
03:12 ET | 347 | 15.095 |
03:14 ET | 2181 | 15.11 |
03:16 ET | 4159 | 15.08 |
03:18 ET | 1502 | 15.11 |
03:20 ET | 2194 | 15.105 |
03:21 ET | 946 | 15.105 |
03:23 ET | 2229 | 15.15 |
03:25 ET | 1874 | 15.18 |
03:27 ET | 2253 | 15.22 |
03:30 ET | 5915 | 15.14 |
03:32 ET | 3091 | 15.15 |
03:34 ET | 3937 | 15.16 |
03:36 ET | 5266 | 15.24 |
03:38 ET | 8779 | 15.3 |
03:39 ET | 5738 | 15.34 |
03:41 ET | 15391 | 15.33 |
03:43 ET | 15858 | 15.38 |
03:45 ET | 12346 | 15.34 |
03:48 ET | 12246 | 15.28 |
03:50 ET | 12753 | 15.25 |
03:52 ET | 13406 | 15.29 |
03:54 ET | 20863 | 15.24 |
03:56 ET | 15582 | 15.23 |
03:57 ET | 12123 | 15.2 |
03:59 ET | 21395 | 15.23 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.4B | -4.9x | --- |
Rigel Pharmaceuticals Inc | 1.4B | -7.2x | --- |
Vir Biotechnology Inc | 1.2B | -2.2x | --- |
Gyre Therapeutics Inc | 1.0B | -6.4x | --- |
Ardelyx Inc | 1.7B | -25.7x | --- |
Nurix Therapeutics Inc | 1.2B | -7.9x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
---|---|
Revenue (TTM) | $237.0M |
Shares Outstanding | 91.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -4.9x |
Price/Sales (TTM) | 5.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -113.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.